ArticleItalian journal of pediatrics2025
Correlation analysis between patent ductus arteriosus and bronchopulmonary dysplasia in premature infants.
Article in Italian journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo evaluate the correlation between patent ductus arteriosus (PDA) and bronchopulmonary dysplasia (BPD) in premature infants.
methodsRetrospective analysis was performed on preterm infants with a gestational age(GA) of less than 32 weeks from 2019 to 2021. PDA premature infants with BPD ( N = 70 ) or not ( N = 224) were enrolled for multivariate logistic regression exploring independent risk factors for BPD in PDA preterm infants. The nomogram model was employed for exhibiting risk factors and receiver operating characteristic curve (ROC) was used to evaluate model performance.
results(1) GA, birth weight (BW) and Apgar (5 min) score in BPD group were significantly lower than non-BPD group (p < 0.0001). (2) BPD group had a higher utilization rate of pulmonary surfactant, more infants receiving oxygen therapy through nasal catheters, and a longer oxygen therapy duration (p < 0.0001). (3) The proportion of haemodynamically significant patent ductus arteriosus(hsPDA)in BPD group was significantly higher than that in non-BPD group (p < 0.05). (4) The incidence of anemia and pulmonary hypertension in BPD group infants was significantly higher than that in non-BPD group (100% and > 50% in BPD, respectively, p < 0.05). (5) The goodness of fit test of calibration curve showed χ2 = 7.136, p = 0.522, and area under curve (AUC) was 0.799.
conclusionsGA, BW and PDA diameter were independent risk factors for PDA merged with BPD. The smaller GA, the lower BW, the larger PDA diameter and the lower Apgar score (5 min), and the higher the risk of BPD in PDA infants.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.